Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Female patients aged 18 years or older at diagnosis of, or progression to, metastatic breast cancer
Patients with a diagnosis of breast cancer with documented metastatic disease and with known date of metastatic disease
Patients with a histologically confirmed HER2+ breast cancer (HER2 testing procedures per routine institutional practice; no tissue re-sampling will be performed. If conducted at another site, documented results must be available).
You may not be if
Patients receiving care for another primary cancer during the study time period.
Clareo Health | Treatment Options in Human Epidermal Growth Factor Receptor 2 (HER2) Positive Metastatic Breast Cancer Patients
